Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Amortization of Deferred Charges (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Amortization of Deferred Charges for 16 consecutive years, with $624000.0 as the latest value for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 536.73% to $624000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 304.28% year-over-year, with the annual reading at $1.3 million for FY2025, 304.28% up from the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $624000.0 at Harvard Bioscience, up from $357000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $624000.0 in Q4 2025, with the low at $70000.0 in Q1 2021.
  • Average Amortization of Deferred Charges over 5 years is $124450.0, with a median of $70000.0 recorded in 2021.
  • The sharpest move saw Amortization of Deferred Charges dropped 29.29% in 2021, then surged 536.73% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $70000.0 in 2021, then changed by 0.0% to $70000.0 in 2022, then changed by 0.0% to $70000.0 in 2023, then surged by 40.0% to $98000.0 in 2024, then soared by 536.73% to $624000.0 in 2025.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $624000.0, $357000.0, and $210000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.